Serum Glial Cell Line-Derived Neurotrophic Factor (sGDNF) Is a Novel Biomarker in Predicting Cirrhosis in Patients with Chronic Hepatitis B.

Guangyue Yang Liping Zhuang Tiantian Sun Yee Hui Yeo Le Tao Wei Zhang Wenting Ma Liu Wu Zongguo Yang Yanqin Yang Dongying Xue Jie Zhang Rilu Feng Matthias P A Ebert Steven Dooley Jeffrey H Albrecht Ping Liu Cheng Liu

Published in: Canadian journal of gastroenterology & hepatology (2022)

Using serum, tissue mRNA, and biopsy data, our study revealed a significant potential of sGDNF as a novel noninvasive biomarker for cirrhosis in CHB patients.

Keyphrases

end stage renal disease
newly diagnosed
hepatitis b virus
prognostic factors
peritoneal dialysis
big data
machine learning
neuropathic pain
spinal cord injury
human health
binding protein